Complete response of merkel cell carcinoma with brain metastases to pembrolizumab and radiotherapy: A case report

<p>Merkel cell carcinoma is a rare, but highly malignant and fast growing skin-cancer with high recurrence-rates, deriving from endothelial and neuroendocrine tissues. For advanced Merkel cell carcinoma prognosis is poor [1] and even under cytotoxic chemotherapy there is only a median progress...

Full description

Saved in:
Bibliographic Details
Main Authors: Ansgar Koechel (Author), Franz-Joachim Hilke (Author), Bernhard Klumpp (Author), Christopher Schroeder (Author), Thomas Eigentler (Author), Diana Lomberg (Author), Claus Garbe (Author), Ulrike Leiter (Author)
Format: Book
Published: Global Journal of Medical and Clinical Case Reports - Peertechz Publications, 2021-06-03.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_2455-5282_000129
042 |a dc 
100 1 0 |a Ansgar Koechel  |e author 
700 1 0 |a  Franz-Joachim Hilke  |e author 
700 1 0 |a  Bernhard Klumpp  |e author 
700 1 0 |a  Christopher Schroeder  |e author 
700 1 0 |a  Thomas Eigentler  |e author 
700 1 0 |a  Diana Lomberg  |e author 
700 1 0 |a  Claus Garbe  |e author 
700 1 0 |a Ulrike Leiter  |e author 
245 0 0 |a Complete response of merkel cell carcinoma with brain metastases to pembrolizumab and radiotherapy: A case report 
260 |b Global Journal of Medical and Clinical Case Reports - Peertechz Publications,   |c 2021-06-03. 
520 |a <p>Merkel cell carcinoma is a rare, but highly malignant and fast growing skin-cancer with high recurrence-rates, deriving from endothelial and neuroendocrine tissues. For advanced Merkel cell carcinoma prognosis is poor [1] and even under cytotoxic chemotherapy there is only a median progression-free survival of only 3 months [2,3]. Even though Merkel cell carcinoma frequently shows lymphatic metastases, it almost never shows cerebral involvement [1]. To our knowledge there are only twelve reported cases of cerebral metastases. Furthermore this is the first reported case of complete response in a patient with advanced Merkel cell carcinoma Stage IV with brain metastases under combined treatment with pembrolizumab and radiotherapy.</p><p><br></p> 
540 |a Copyright © Ansgar Koechel et al. 
546 |a en 
655 7 |a Case Report  |2 local 
856 4 1 |u https://doi.org/10.17352/2455-5282.000129  |z Connect to this object online.